logo

For the Inventor, By the Inventor

Plainsboro, NJ, United States of America

Yiu-kuen T Lam

This inventor holds 12 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1988-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yiu-kuen T Lam. Retrieved from https://idiyas.com/inventor/yiu-kuen-t-lam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1988-1993

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5242938 - Derivatives of virginiamycin M1 (1993-09-07),
2. 5240910 - Antihypertensive compounds produced by fermentation (1993-08-31),
3. 5233050 - Antimigraine alkyl indole (1993-08-03),
4. 5189050 - Fermentation analogs of Virginiamycin M.sub.1 to treat panic and anxiety (1993-02-23),
5. 5137900 - Therapeutic virginiamycin M.sub.1 analogs (1992-08-11),
6. 5006466 - Fermentation analogs of virginiamycin M.sub.1 (1991-04-09),
7. 4981980 - Drug for treating manic depression (1991-01-01),
8. 4942230 - Process for preparing synthetic virginiamycin M.sub.1 analogs (1990-07-17),
9. 4894370 - Compositions having fermentation analogs of virginiamycin M.sub.1 as (1990-01-16),
10. 4859690 - Therapeutic virginiamycin M.sub.1 analogs (1989-08-22),
11. 4772595 - Synthetic virginiamycin M1 analogs (1988-09-20),
12. 4762923 - Fermentation analogs of virginiamycin M1 (1988-08-09),

Title: The Innovations of Yiu-kuen T Lam: Pioneering Antibiotic and Antihypertensive Research

Introduction

Yiu-kuen T Lam is a prominent inventor based in Plainsboro, NJ, whose contributions to pharmaceutical sciences have significantly advanced antibiotic and antihypertensive treatments. With a remarkable portfolio of 12 patents, Lam stands out as a key figure in the innovative landscape of medicinal chemistry.

Latest Patents

Among his notable innovations are his latest patents, which include derivatives of virginiamycin M1 and novel antihypertensive compounds. The first patent involves dicarbonyloxy, carbonyloxy, carbanilate, and dihydroxy derivatives of virginiamycin M1, which are recognized for their effectiveness in binding gastrin and brain CCK receptors, thereby serving as useful antibiotics. The second patent highlights novel cyclic depsipeptides derived from the culture of Microbispora that function as antagonists of the endothelin receptor, making them valuable in treating cardiovascular disorders. The cyclical depsipeptides detailed in this invention showcase compounds including N-(pyrrol-2-carboxy) - L-phe, D-allo-Thr, D-Phe, D-Ala, and D- or L-dihydroxyphenyl-Gly.

Career Highlights

Yiu-kuen T Lam is affiliated with Merck & Company, Inc., where he has employed his expertise to further drug development. His work focuses largely on therapeutic solutions that address significant health challenges, reflecting his commitment to enhancing medical outcomes for patients.

Collaborations

Throughout his career, Lam has collaborated with esteemed colleagues such as Deborah L Zink and Raymond S Chang. These partnerships have played a vital role in advancing his research and expanding the applications of his innovative compounds.

Conclusion

Yiu-kuen T Lam exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing effective antibiotic and antihypertensive therapies continues to impact the field, promising better health solutions for individuals worldwide. The legacy of his patents will undoubtedly pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…